Liver Metastasis Recruiting Phase 2 Trials for Bevacizumab (DB00112)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029622 (Liver Metastasis) | Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01923987 | Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis | Treatment |